Brief: Iovance Biotherapeutics Inc - Jean-Marc Bellemin To Resign As CFO
13/06/2025 22:22
June 13 (Reuters) - Iovance Biotherapeutics Inc IOVA.O: IOVANCE BIOTHERAPEUTICS INC - JEAN-MARC BELLEMIN TO RESIGN AS CFO - SEC FILING Further company coverage: IOVA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies